46 related articles for article (PubMed ID: 18470917)
1. Uncertain pathogenicity of MSH2 variants N127S and G322D challenges their classification.
Ollila S; Dermadi Bebek D; Greenblatt M; Nyström M
Int J Cancer; 2008 Aug; 123(3):720-4. PubMed ID: 18470917
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of pathogenicity in human MSH2 missense mutants.
Ollila S; Dermadi Bebek D; Jiricny J; Nyström M
Hum Mutat; 2008 Nov; 29(11):1355-63. PubMed ID: 18951462
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
[TBL] [Abstract][Full Text] [Related]
4. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair.
Wielders EA; Hettinger J; Dekker R; Kets CM; Ligtenberg MJ; Mensenkamp AR; van den Ouweland AM; Prins J; Wagner A; Dinjens WN; Dubbink HJ; van Hest LP; Menko F; Hogervorst F; Verhoef S; te Riele H
J Med Genet; 2014 Apr; 51(4):245-53. PubMed ID: 24501230
[TBL] [Abstract][Full Text] [Related]
6. A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants.
Drost M; Zonneveld JB; van Hees S; Rasmussen LJ; Hofstra RM; de Wind N
Hum Mutat; 2012 Mar; 33(3):488-94. PubMed ID: 22102614
[TBL] [Abstract][Full Text] [Related]
7. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene.
Banville N; Geraghty R; Fox E; Leahy DT; Green A; Keegan D; Geoghegan J; O'Donoghue D; Hyland J; Sheahan K
Hum Pathol; 2006 Nov; 37(11):1498-502. PubMed ID: 16996571
[TBL] [Abstract][Full Text] [Related]
8. MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system.
Belvederesi L; Bianchi F; Galizia E; Loretelli C; Bracci R; Catalani R; Amati M; Cellerino R
Hum Mutat; 2008 Nov; 29(11):E296-309. PubMed ID: 18781619
[TBL] [Abstract][Full Text] [Related]
9. Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants.
Houlleberghs H; Dekker M; Lantermans H; Kleinendorst R; Dubbink HJ; Hofstra RM; Verhoef S; Te Riele H
Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4128-33. PubMed ID: 26951660
[TBL] [Abstract][Full Text] [Related]
10. A novel missense MSH2 gene mutation in a patient of a Korean family with hereditary nonpolyposis colorectal cancer.
Park SJ; Lee KA; Park TS; Kim NK; Song J; Kim BY; Choi JR
Cancer Genet Cytogenet; 2008 Apr; 182(2):136-9. PubMed ID: 18406877
[TBL] [Abstract][Full Text] [Related]
11. A rare MSH2 mutation causes defective binding to hMSH6, normal hMSH2 staining, and loss of hMSH6 at advanced cancer stage.
Loconte DC; Patruno M; Lastella P; Di Gregorio C; Grossi V; Forte G; Ingravallo G; Varvara D; Bagnulo R; Simone C; Resta N; Stella A
Hum Pathol; 2014 Oct; 45(10):2162-7. PubMed ID: 25106712
[TBL] [Abstract][Full Text] [Related]
12. Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes.
Huang RL; Chao CF; Ding DC; Yu CP; Chang CC; Lai HC; Yu MH; Liu HS; Chu TY
Cancer Genet Cytogenet; 2004 Sep; 153(2):108-14. PubMed ID: 15350299
[TBL] [Abstract][Full Text] [Related]
13. Truncation of the MSH2 C-terminal 60 amino acids disrupts effective DNA mismatch repair and is causative for Lynch syndrome.
Wielders E; Delzenne-Goette E; Dekker R; van der Valk M; Te Riele H
Fam Cancer; 2017 Apr; 16(2):221-229. PubMed ID: 27873144
[TBL] [Abstract][Full Text] [Related]
14. A database to support the interpretation of human mismatch repair gene variants.
Ou J; Niessen RC; Vonk J; Westers H; Hofstra RM; Sijmons RH
Hum Mutat; 2008 Nov; 29(11):1337-41. PubMed ID: 18951442
[TBL] [Abstract][Full Text] [Related]
15. MSH6 germline mutations are rare in colorectal cancer families.
Peterlongo P; Nafa K; Lerman GS; Glogowski E; Shia J; Ye TZ; Markowitz AJ; Guillem JG; Kolachana P; Boyd JA; Offit K; Ellis NA
Int J Cancer; 2003 Nov; 107(4):571-9. PubMed ID: 14520694
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic oligodendroglioma in an adolescent with Lynch syndrome.
Heath JA; Ng J; Beshay V; Coleman L; Lo P; Amor DJ
Pediatr Blood Cancer; 2013 Jun; 60(6):E13-5. PubMed ID: 23255519
[TBL] [Abstract][Full Text] [Related]
17. No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients.
Steinke V; Rahner N; Morak M; Keller G; Schackert HK; Görgens H; Schmiegel W; Royer-Pokora B; Dietmaier W; Kloor M; Engel C; Propping P; Aretz S;
Eur J Hum Genet; 2008 May; 16(5):587-92. PubMed ID: 18301448
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae.
Gammie AE; Erdeniz N; Beaver J; Devlin B; Nanji A; Rose MD
Genetics; 2007 Oct; 177(2):707-21. PubMed ID: 17720936
[TBL] [Abstract][Full Text] [Related]
19. Lynch syndrome-associated mutations in MSH2 alter DNA repair and checkpoint response functions in vivo.
Mastrocola AS; Heinen CD
Hum Mutat; 2010 Oct; 31(10):E1699-708. PubMed ID: 20672385
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer and a novel MSH2 germline alteration.
Lindor NM; Petersen GM; Spurdle AB; Thompson B; Goldgar DE; Thibodeau SN
Pancreas; 2011 Oct; 40(7):1138-40. PubMed ID: 21926548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]